series-a
Stage
2018
Founded
1
Investors
About
ReproNovo is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for reproductive medicine and women’s health, focusing on male and female infertility as well as uterine health.
Explore ReproNovo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.